FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127086861> ?p ?o ?g. }

• W2127086861 endingPage "2472" @default.
• W2127086861 startingPage "2463" @default.
• W2127086861 abstract "The antibody HMB45 is used to diagnose lymphangioleiomyomatosis, a hyperproliferative disorder of lung smooth muscle cells with mutations in both alleles of either TSC1 or TSC2. A subset of these tumor cells expresses the melanoma-associated antigens gp100 and melanoma antigen recognized by T cells (MART-1). To explore the feasibility of targeting tumors in lymphangioleiomyomatosis by melanoma immunotherapy, we therefore assessed melanoma target antigen expression and existing immune infiltration of affected tissue compared with normal lung and melanoma as well as the susceptibility of cultured lymphangioleiomyomatosis cells to melanoma reactive cytotoxic T lymphocytes in vitro. Tumors expressed tyrosinase-related proteins 1 and 2 but not tyrosinase, in addition to gp100 and MART-1, and were densely infiltrated by macrophages, but not dendritic cells or T cell subsets. Although CD8(+) lymphocytes were sparse compared with melanoma, cells cultured from lymphangioleiomyomatosis tissue were susceptible to cytotoxic, gp100 reactive, and major histocompatibility complex class I restricted CD8(+) T cells in functional assays. Responder T cells selectively clustered and secreted interferon-gamma in response to HLA-matched melanocytes and cultured lymphangioleiomyomatosis cells. This reactivity exceeded that based on detectable gp100 expression; thus, tumor cells in lymphangioleiomyomatosis may process melanosomal antigens different from melanocytic cells. Therefore, boosting immune responses to gp100 in lymphangioleiomyomatosis may offer a highly desirable treatment option for this condition." @default.
• W2127086861 created "2016-06-24" @default.
• W2127086861 creator A5007649970 @default.
• W2127086861 creator A5008927767 @default.
• W2127086861 creator A5010786898 @default.
• W2127086861 creator A5026429291 @default.
• W2127086861 creator A5042729967 @default.
• W2127086861 creator A5058458428 @default.
• W2127086861 creator A5065103169 @default.
• W2127086861 creator A5068018913 @default.
• W2127086861 creator A5073189087 @default.
• W2127086861 creator A5074825262 @default.
• W2127086861 creator A5077504226 @default.
• W2127086861 creator A5088896967 @default.
• W2127086861 date "2009-12-01" @default.
• W2127086861 modified "2023-10-16" @default.
• W2127086861 title "Melanoma-Associated Antigen Expression in Lymphangioleiomyomatosis Renders Tumor Cells Susceptible to Cytotoxic T Cells" @default.
• W2127086861 cites W1964674650 @default.
• W2127086861 cites W1966284693 @default.
• W2127086861 cites W1975815647 @default.
• W2127086861 cites W1987291388 @default.
• W2127086861 cites W1999980753 @default.
• W2127086861 cites W2006928355 @default.
• W2127086861 cites W2007036195 @default.
• W2127086861 cites W2008494452 @default.
• W2127086861 cites W2009510442 @default.
• W2127086861 cites W2031650264 @default.
• W2127086861 cites W2034021163 @default.
• W2127086861 cites W2034456929 @default.
• W2127086861 cites W2038028072 @default.
• W2127086861 cites W2050790870 @default.
• W2127086861 cites W2055288244 @default.
• W2127086861 cites W2062948694 @default.
• W2127086861 cites W2075880910 @default.
• W2127086861 cites W2077468000 @default.
• W2127086861 cites W2088335117 @default.
• W2127086861 cites W2111191770 @default.
• W2127086861 cites W2116649189 @default.
• W2127086861 cites W2117995885 @default.
• W2127086861 cites W2119793652 @default.
• W2127086861 cites W2121554109 @default.
• W2127086861 cites W2130185552 @default.
• W2127086861 cites W2144028095 @default.
• W2127086861 cites W2146627961 @default.
• W2127086861 cites W2405367092 @default.
• W2127086861 cites W4238356169 @default.
• W2127086861 doi "https://doi.org/10.2353/ajpath.2009.090525" @default.
• W2127086861 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2789635" @default.
• W2127086861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19893037" @default.
• W2127086861 hasPublicationYear "2009" @default.
• W2127086861 type Work @default.
• W2127086861 sameAs 2127086861 @default.
• W2127086861 citedByCount "34" @default.
• W2127086861 countsByYear W21270868612012 @default.
• W2127086861 countsByYear W21270868612013 @default.
• W2127086861 countsByYear W21270868612015 @default.
• W2127086861 countsByYear W21270868612016 @default.
• W2127086861 countsByYear W21270868612018 @default.
• W2127086861 countsByYear W21270868612019 @default.
• W2127086861 countsByYear W21270868612020 @default.
• W2127086861 countsByYear W21270868612021 @default.
• W2127086861 countsByYear W21270868612022 @default.
• W2127086861 countsByYear W21270868612023 @default.
• W2127086861 crossrefType "journal-article" @default.
• W2127086861 hasAuthorship W2127086861A5007649970 @default.
• W2127086861 hasAuthorship W2127086861A5008927767 @default.
• W2127086861 hasAuthorship W2127086861A5010786898 @default.
• W2127086861 hasAuthorship W2127086861A5026429291 @default.
• W2127086861 hasAuthorship W2127086861A5042729967 @default.
• W2127086861 hasAuthorship W2127086861A5058458428 @default.
• W2127086861 hasAuthorship W2127086861A5065103169 @default.
• W2127086861 hasAuthorship W2127086861A5068018913 @default.
• W2127086861 hasAuthorship W2127086861A5073189087 @default.
• W2127086861 hasAuthorship W2127086861A5074825262 @default.
• W2127086861 hasAuthorship W2127086861A5077504226 @default.
• W2127086861 hasAuthorship W2127086861A5088896967 @default.
• W2127086861 hasBestOaLocation W21270868611 @default.
• W2127086861 hasConcept C142724271 @default.
• W2127086861 hasConcept C147483822 @default.
• W2127086861 hasConcept C154317977 @default.
• W2127086861 hasConcept C167672396 @default.
• W2127086861 hasConcept C202751555 @default.
• W2127086861 hasConcept C203014093 @default.
• W2127086861 hasConcept C2777658100 @default.
• W2127086861 hasConcept C2778980267 @default.
• W2127086861 hasConcept C2779997425 @default.
• W2127086861 hasConcept C502942594 @default.
• W2127086861 hasConcept C55493867 @default.
• W2127086861 hasConcept C71924100 @default.
• W2127086861 hasConcept C86803240 @default.
• W2127086861 hasConcept C8891405 @default.
• W2127086861 hasConceptScore W2127086861C142724271 @default.
• W2127086861 hasConceptScore W2127086861C147483822 @default.
• W2127086861 hasConceptScore W2127086861C154317977 @default.
• W2127086861 hasConceptScore W2127086861C167672396 @default.
• W2127086861 hasConceptScore W2127086861C202751555 @default.
• W2127086861 hasConceptScore W2127086861C203014093 @default.
• W2127086861 hasConceptScore W2127086861C2777658100 @default.

• next